Pharmaceutical Sciences
Pharmacy Practice
Social and Administrative Pharmacy
310 Drugs and Their Actions. I; 2 cr (B-I). Introduces students to the biological effects of drugs on human health. Emphasis on how drugs, especially those used in diseases of major human health significance, act in the body. Drugs that are abused also will be covered. This course is not intended for medical, nursing, pharmacy, and physician assistant students. P: HS or coll chem & biol, or cons inst. Not open for cr to Nursing, Phys Asst, & School of Pharm stdts.
401 Survey of Pharmacology. I; 3 cr (B-I). Pharmacological and toxicological actions and therapeutic use of important drugs. P: Physiol 335; Biochem 201 or 501 or Bmolchem 314. Not open for credit to School of Pharm stdts.
420 Introduction to Drug Action and Drug Delivery I. I; 4 cr (P-I). Applications of physical principles and modern methods of analysis to pharmaceutical systems. P: DPM-1 or Tox-3 st; Chem 103-104 & 343, 344, 345, Math 221, & Physics 103-104.
421 Introduction to Drug Action and Drug Delivery II. II; 4 cr. A conceptual introduction to the way that drugs act and are processed in vivo, including receptor theory, ligand-macromolecule binding, biopharmaceutics, drug metabolism, pharmacokinetics, and pharmacodynamics. P: DPM-1 or Tox-3 st; Phm Sci 420, Physiol 335.
430 Biological Interactions with Materials. (Crosslisted with BME) II; 3 cr. This course addresses the range of materials currently being utilized for various biomedical applications, the biological systems governing biomaterial applications, analytical techniques pertinent to biomaterial evaluation, and selected major medical applications in which biomaterials play an important role. P: 1 yr of general biol or two semesters of zool, & 1 semester of organic chem, or cons inst.
432 Pharmaceutical Biochemistry. I; 4 cr (P-I). Chemistry of metabolic processes and products of living matter with emphasis on pharmaceutical and medicinal aspects as well as recombinant DNA technology. Laboratory experience with the chemistry of metabolic processes, products of living matter and recombinant DNA. P: DPH-1 or Tox-3 st.
490 Selected Topics in Pharmaceutical Sciences. I, II; 1-4 cr. P: Graded on a lettered basis; requires cons inst.
491 Selected Topics in Pharmaceutical Sciences. I, II; 1-4 cr. P: Cons inst.
492 Selected Topics in Pharmaceutical Sciences. I, II; 1-4 cr. P: Cons inst.
493 Selected Topics in Pharmaceutical Sciences. I, II; 1-4 cr. P: Cons inst.
494 Selected Topics in Pharmaceutical Sciences. I, II; 1-4 cr. P: Cons inst.
495 Selected Topics in Pharmaceutical Sciences. I, II; 1-4 cr. P: Cons inst.
521 Pharmacology I. I; 3 cr. Pharmacological actions of important drugs, including drugs that affect the peripheral nervous system, the central nervous system, and the gastrointestinal tract. P: DPM-2 or Tox-4 st; Bact 303, Physiol 335, Phm Sci 432, Path 404.
522 Pharmacology II. II; 3 cr. Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure. P: Phm Sci 521.
531 Medicinal Chemistry I. 2 cr (P-I). Chemistry of medicinal products, including cholinergic, adrenergic, dopaminergic and serotonergic agents, antidepressants, sedative/hypnotics, antianxiety drugs, opioid drugs acting at histamine receptors, and inhibitors of mediator release. P: Phm Sci 432.
532 Medicinal Chemistry II. II; 2 cr. Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors. P: Phm Sci 531.
540 Drug Delivery Systems. I; 4 cr. The application of physical, chemical and biological principles to the study of drug delivery using a variety of solid, solution and disperse systems as dosage forms. Rationale for therapeutic use, formulation and manufacture, and evaluation of stability and bioavailability. P: Phm Sci 420, 421; con reg in Phm Sci 541.
541 Drug Delivery Systems Laboratory I. I; 3 cr. Introductory laboratory course in compounding and dispensing of pharmaceutical dosage forms, including sterile products. Includes practice in interpretation of prescription orders, pharmaceutical calculations, compounding procedures, physical manipulation of drugs and dosage form components, and product packaging and labeling. P: Phm Sci 420, 421; con reg in Phm Sci 540.
542 Drug Delivery Systems Laboratory II. II; 3 cr. Advanced extemporaneous prescription compounding and preparation of sterile products, with emphasis on physico-chemical stability and compatibility of drugs and dosage forms. Also addresses principles of appraisal, comparison, and selection of appropriate commercial brand name and generic products. P: Phm Sci 540, 541, Stat 541; con reg in Phm Prac 570, S&A Phm 511.
558 Laboratory Techniques in Pharmacology and Toxicology. I; 2 cr. Basic laboratory techniques employed in pharmacological and toxicological research. P: Jr st in the B.S. Pharmacology & Toxicology program.
623 Pharmacology III. I; 2 cr. Pharmacological actions of important drugs, including antimicrobial and antiviral drugs, hormones and other drugs affecting the endocrine system. P: For DPM stdts, Phm Sci 522; for TOX stdts, con reg in Phm Sci 521.
625 Toxicology I. (Crosslisted with M&Envtox, Medicine, Oncology, Path, Phmcol-M, Pop Hlth, Ahabs) I; 3 cr (B-A). Basic principles of toxicology and biochemical mechanisms of toxicity in mammalian species and man. Correlation between morphological and functional changes caused by toxicants in different organs of the body. P: Biochem 501 & Physiol 335 or cons inst. Path 401 & Phmcol 401 or equiv recommended.
626 Toxicology II. (Crosslisted with M&Envtox, Medicine, Path, Phmcol-M, Pop Hlth, Ahabs) II; 3 cr (B-A). A course surveying the basic methods and fundamental biochemical mechanisms of toxicity. Toxicity in mammalian organ systems, techniques for evaluating toxicity, as well as mechanisms of species specificity, and environmental interactions (with toxicant examples) are presented. P: Env Tox 625 or cons inst.
635 Drug Interactions. I; 1-2 cr. This course will develop the student's ability to use physiological, pharmacological, physical-chemical, pharmacokinetic, and pharmacodynamic concepts to analyze and assess drug-drug interactions. P: Ph-3 or DPM-1 st, or cons inst.
638 Nonprescription Medications. I; 2-3 cr. The lecture provides students with the knowledge needed to perform triage and make therapeutic recommendations for illnesses commonly encountered in ambulatory pharmacy practice. The lab expands upon lecture knowledge, provides active learning strategies for teaching triage skills, and provides opportunities to practice the application of triage skills. P: Phm Prac 555-556 & Phm Sci 521-522.
640 Substance Abuse and Chemical Dependence. II; 2 cr. This course addresses the pharmacology and toxicology of abused and dependence-producing substances, as well as treatment approaches for alcoholism, nicotine dependence, opioid dependence, and cocaine dependence. P: Phm Sci 401 or 471, 472, 473, 474 or equiv, or cons inst.
645 Pharmaceutical Biotechnology and Pharmacogenomics. I; 2-3 cr. Facilitates the understanding and application of the principles of pharmaceutical biotechnology and pharmacogenomics. The third, optional, elective credit, open only to Pharm.D. students, will consist of clinical case studies in biotechnology and pharmacogenomics, to apply theory to clinical pharmacy practice. P: Phm Sci 432 & DPH-3 st, or cons inst; 2 cr required, with 3rd cr open only to Pharm.D. stdts as a prof elective.
677 Natural Product Chemistry and Engineered Biosynthesis. Alt yrs.; II; 3-4 cr (P-A). For undergraduate seniors and graduate students interested in the biosynthesis of natural products and genetic engineering of second metabolism for drug discovery and development. Covers these natural products classes: fatty acids, polyketides, carbohydrates, terpenoids, metabolites of shikimate origin, peptides and B-lactams, and alkaloids. P: Biochem 507-508, or Chem 547 or 641, or cons inst.
679 Pharmacology and Toxicology Senior Seminar. II; 1 cr. Students review current pharmacological and toxicological literature and research in academia, industry, and government. P: Sr st in the B.S. Pharmacology & Toxicology program.
691 Senior Thesis. I, II; 2 cr (A).
692 Senior Thesis. I, II; 2 cr (A).
699 Advanced Independent Study. I, II; 0-3 cr (A). P: Cons inst.
401 Clinical Medicine for Physician Assistants II. (Crosslisted with Phy Asst) II; 5 cr. Continuation of 400. P: Jr st. Phy Asst major or Pharm D major.
425 Introduction to Pharmaceutical Care Clerkship I. I; 0 cr. This required Pharm D. experiential course provides students with the opportunity to learn to communicate with patients and their families by participating in community service learning activities. Students will be introduced to patients and their families with diverse cultural, physical, and psychosocial backgrounds. Students will also observe the provision of direct pharmaceutical care in ambulatory and institutional settings. P: DPM-1 st; con reg in S&A Phm 411.
426 Introduction to Pharmaceutical Care Clerkship II. II; 1 cr. This required Pharm D. experiential course complements didactic course work in communication and the role of the pharmacist in the health care system. Students will observe the provision of direct pharmaceutical care in ambulatory and institutional settings and observe role models. P: DPM-1 st, Phm Prac 425, S&A Phm 411; con reg in S&A Phm 414.
440 Therapeutics-Physician Assistants and Adv Practice Nurses, Part I. I; 1 cr. The course will emphasize therapeutic and drug product selection, including issues of efficacy, potential toxicities, compliance, monitoring parameters, drug interactions, and cost. The focus of the course will be on chronic disease management, treatment of acute minor illnesses, and symptomatic therapies. P: Jr st in Phy Asst prog; Grad st in School of Nursing, or cons inst. No cr for School of Pharmacy stdts.
441 Therapeutics-Physician Assistants and Adv Practice Nurses, Part II. II; 1 cr. Continuation of Pharmacy Practice 440. P: Phm Prac 440; Jr st in Phy Asst prog, Grad st in School of Nursing, or cons inst; no cr for School of Pharmacy stdts.
448 A Team Approach to Emergency Care. (Crosslisted with Phy Asst, Medicine, Nursing) II; 3-4 cr. Concepts and skills related to the provision of advanced emergency medical care, in primary and secondary settings, by a health care team. P: PA classification or cons inst.
470 Computer Applications in Pharmacy Practice. I; 3 cr. Develops skills applicable to community and hospital pharmacy practice settings. Emphasis on database and computer applications unique to pharmacy practice. No prior computer experience or knowledge is necessary. P: Enrollment in School of Pharmacy.
490 Selected Topics in Pharmacy Practice. I, II; 1-4 cr. P: Ph-2 st & cons inst.
495 Selected Topics in Pharmacy Practice. I, II; 1-4 cr. P: Graded on a Cr/N basis; requires Ph-1 st & cons inst.
525 Introduction to Pharmaceutical Care Clerkship III. I; 0 cr. This required Pharm.D. experiential course integrates prior and current didactic course work in communications, pharmacotherapy, and pathophysiology into the provision of pharmaceutical care to hospitalized or ambulatory patients. The student will observe and participate in the provision of direct pharmaceutical care. P: Phm Prac 426; con reg Phm Prac 555.
526 Introduction to Pharmaceutical Care Clerkship IV. II; 1 cr. This required Pharm.D. experiential course integrates prior and current didactic course work in communications, pharmacotherapy, and pathophysiology into the provision of pharmaceutical care to hospitalized or ambulatory patients. The student will observe and participate in the provision of direct pharmaceutical care. P: Phm Prac 525; con reg Phm Prac 556.
550 Fluid and Electrolyte Therapy. I; 2 cr. Clinical management of disorders of fluid, electrolytes, and acid-base in patients with normal and abnormal homeostatic mechanisms. Also included is parenteral nutritional support. P: Ph-3 or DPM-1 st, or cons inst.
555 Pharmacotherapy I. I; 4 cr. Clinical application of medications in the management of various disease states. Assessment and therapeutic monitoring of drug therapy with emphasis on the concepts of pharmacokinetics/dynamics, drug interactions, pharmacy practice, and patient counseling. Topics include medical nomenclature, basic clinical laboratory values, clinical pharmacokinetics, and neuropsychiatric therapeutics. P: DPH-2 st or cons inst.
556 Pharmacotherapy II. II; 4 cr. Clinical application of medications in the management of various disease states. Assessment and therapeutic monitoring of disease states and drug therapy using the concepts of pharmacokinetics/dynamics, drug interactions, pharmacy practice and patient counseling. Topics include cardiovascular and pulmonary therapeutics. P: Phm Sci 521, Phm Prac 555, & DPH-2 st, or cons inst.
570 Drug Literature Evaluation. II; 2 cr. Fundamentals of literature evaluation to enable students to make decisions regarding the clinical use of drugs. P: For entry-level Pharm D. stdts, DPM-2 st, Phm Prac 555, & con reg in Phm Prac 556. For all other stdts, cons inst.
600 Interdisciplinary Rural Primary Health Care Practice. (Crosslisted with Nursing, Phy Asst, Soc Work) I; 2 cr (D). Using a framework of interdisciplinary health care teams and community-based practice models, the course focuses on the provision of primary health care services in rural and underserved populations. P: Sr st in a health professions prgm e.g. nurs, phy asst, pharm, soc wrk, med, nutr, occ ther, phy ther or cons inst.
608 Safety and Quality in the Medication Use System. II; 3 cr. Addresses the problems of medication errors and quality in health care, problem resolutions, methods of assessment, and intervention implementation and quality management. P: DPH-3 st or cons inst.
612 Radiopharmaceuticals. I; 2 cr (P-D). A survey of the clinical diagnostic and therapeutic use of radioactive pharmaceuticals. Included is a review of nuclear physics, radiation biology, radiation chemistry, regulatory issues, and radiation safety, as these areas relate to the synthesis, formulation, dispensing, and administration of radiopharmaceuticals. P: Ph-3 or DPM-1 st, or cons inst.
625 Introduction to Pharmaceutical Care Clerkship V. I; 0 cr. This required Pharm.D. experiential course integrates prior didactic course work in communications, pharmacotherapy, pathophysiology, and drug literature evaluation into the provision of pharmaceutical care to hospitalized and ambulatory patients. The student will observe and participate in the provision of direct pharmaceutical care. P: Phm Prac 526; con reg Phm Prac 655.
626 Introduction to Pharmaceutical Care Clerkship VI. II; 1 cr. This required Pharm.D. experiential course integrates prior course work in communications, pharmacotherapy, pathophysiology, and drug literature evaluation into the provision of pharmaceutical care to hospitalized and ambulatory patients. The student will observe and participate in the provision of direct pharmaceutical care. P: Phm Prac 625; con reg Phm Prac 656.
650 Comprehensive Immunization Delivery. II; 1 cr (A). Addresses vaccine-preventable diseases and the implementation of pharmacy-based immunization delivery programs. P: Phm Prac 655 or cons inst.
655 Pharmacotherapy III. I; 4 cr. Clinical application of medications in the management of various disease states. Assessment and therapeutic monitoring of disease states and drug therapy using the concepts of pharmacokinetics/dynamics, drug interactions, pharmacy practice and patient counseling. Topics include various renal, endocrine, gastrointestinal, rheumatologic and immunologic disease therapeutics. P: DPM-3 st, or cons inst.
656 Pharmacotherapy IV. II; 4 cr. Clinical application of medications in the management of various disease states. Assessment and therapeutic monitoring of disease states and drug therapy using the concepts of pharmacokinetics/dynamics, drug interactions, pharmacy practice and patient counseling. Topics include hematology/oncology and infectious disease therapeutics. P: DPM-3 st, or cons inst.
664 Veterinary Pharmacy Clerkship. I, II, SS; 2-8 cr. Practical experience in a veterinary medicine environment with emphasis on the drug treatment of diseases in animals. P: Ph-3 st.
665 Nuclear Pharmacy Clerkship. I, II, SS; 2-8 cr. Practical experience in providing pharmaceutical care involving radiopharmaceuticals to both hospitalized and ambulatory patients in an academic hospital environment. Active involvement in the distributory functions of compounding and dispensing unit dose radiopharmaceuticals, as well as the associated patient-oriented functions, administrative functions, and consultative interactions with nuclear medicine personnel. P: Phm Prac 612 and cons inst.
670 Veterinary Therapeutics. I, II; 1-2 cr. Presentation and discussion of topics that involve the therapeutic management of disease states of companion, food, and exotic animals. Emphasis is placed upon the principles of drug regulations, drug therapy, toxicology, and available commercial products. P: Ph-3 st or cons inst.
672 Herbals, Homeopathy, and Dietary Supplements. (Crosslisted with Nutr Sci) II; 2-3 cr. Covers regulations and clinical science regarding the use of herbals, homeopathic remedies, and dietary supplements, focusing on peer-reviewed studies and integration with allopathic drugs; includes discussion of marketing issues. P: Phm Sci 432 or Biochem 501 or Bmolchem 314; Physiol 335; or cons inst.
675 Women's Health Pharmacotherapy. II; 2 cr. The pharmacotherapy of disease prevention and treatment for women, including pharmacotherapy unique to women and the pharmacotherapy of illnesses that are more prevalent in women than in men. Additional women's health issues are addressed. P: Phm Sci 521, 522, 623, or Phm Prac 440 or Phmcol-M 717 or cons inst.
691 Senior Thesis. I, II; 2 cr.
692 Senior Thesis. I, II; 2 cr.
699 Advanced Independent Study. I, II; 0-3 cr (A). P: Cons inst.
105 Health Care Systems: Interdisciplinary Approach. (Crosslisted with Nursing, Soc Work, Ther Sci) I, II; 2 cr (S-E). Introduction to health care systems. Factors affecting health and the value placed on health, the delivery of health care in different settings, the roles of various health workers, and the sociological and economic aspects of health care. Does not count as a B.S.-Pharmacy professional elective. P: Open to all undergrads. PRN's & NUR's must register for 2 cr.
401 History of Pharmacy. (Crosslisted with Hist Sci) II; 2 cr (H-I). Pharmaceutical field, from antiquity to modern medical care; professional; structuring in principal countries of the West. P: Jr st or cons inst.
411 Psychosocial and Management Aspects of Pharmacy. I; 3 cr. Introduction to the patient's perspective of health, illness, and patient-provider interactions, including educational assessment and consultation related to medication use. Management concepts are applied to strategies and approaches for improved patient care processes and systems, focusing on enhanced patient outcomes. P: Soc 210 or 211, or Anthro 100 or 104, & Psych 202 or 530.
414 Pharmacy in the Health Care System. II; 3 cr. Introduction to the health care system and pharmacy within it. Fundamentals of finance, economics, and pharmacoeconomic decision analysis in pharmacy practice. Marketing and the behavior of firms and consumers in pharmacy markets. P: DPH-1 st, S&A Phm 411.
490 Selected Topics in Social and Administrative Pharmacy. I, II; 1-4 cr. P: Graded on a lettered basis; requires cons inst.
495 Selected Topics in Social and Administrative Pharmacy. I, II; 1-4 cr. P: Graded on a Cr/N basis; requires Ph-1 st & cons inst.
511 Pharmacy Law and Regulation. II; 2-3 cr. Federal and Wisconsin laws related to drug manufacture, drug distribution, drug use, and pharmacy practice. P: DPM-2 st; S&A Phm 411, 414, 510.
561 Greek and Roman Medicine and Pharmacy. (Crosslisted with Classics, History, Med Hist, Hist Sci) I; 3 cr (H-D). Greek and Roman medicine and drug lore from the Pre-Socratics to Oribasius (c. 600 B.C.- A.D. 350), including the backgrounds of ancient Egyptian and Mesopotamian medicine. P: Jr or Sr st, or cons inst.
562 Byzantine Medicine and Pharmacy. (Crosslisted with History, Med Hist, Hist Sci, Medieval) II; 3 cr (H-D). Byzantine and Islamic medicine and drug lore from Oribasius to the beginnings of the Italian Renaissance (c. 350- c. 1400 A.D.). P: Jr or Sr st or cons inst.
618 Professional Decision-Making in Pharmacy Practice. I; 2-3 cr. Application of ethical theory to problems in pharmacy practice. Emphasis on contemporary patient care situations and evolving issues related to drug technology, drug use, and patient-pharmacist relations. P: DPH-3 st, S&A Phm 511, & Phm Prac 556; 2 cr required, 3rd cr avail as a professional elective.
622 Proseminar in Social and Administrative Pharmacy. I, II; 1-3 cr (S-D). Problems in pharmaceutical sociology, psychology, management, finance and economics, including: drug prescribing/use, distribution, and payment; patient care and pharmaceutical service delivery; pharmaceutical industry; and pharmaceutical policy and regulation . May be repeated. P: DPH-1 or Jr st.
630 Pharmacy Finance and Reimbursement. I; 3 cr. Analysis and evaluation of financial operations in community pharmacy practice, including third-party reimbursement systems and other factors influencing financial operations. P: S&A Phm 411 & 412.
652 Pharmacist Communication: Educational and Behavioral Interventions. II; 2 cr. Intermediate principles of pharmacist communication with patients and other care givers; weekly communications laboratory provides opportunity to refine skills in listening, interviewing, counseling, and use of various educational and behavioral strategies to improve drug use. P: DPM-3 st & S&A Phm 411.
691 Senior Thesis. I, II; 2 cr.
692 Senior Thesis. I, II; 2 cr.
699 Advanced Independent Study. I, II; 0-3 cr (A). P: Cons inst.